4.5 Article

Geranylgeranylation but Not GTP-Loading of Rho GTPases Determines T Cell Function

期刊

SCIENCE SIGNALING
卷 1, 期 12, 页码 -

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/stke.112pt3

关键词

-

向作者/读者索取更多资源

Rho guanosine triphosphatases (GTPases) orchestrate signaling pathways leading to cell migration. They are typically responsible for the organization of actin filaments that support actomyosin contractility and cell-body translocation. The function of Rho GTPases depends on GTP-loading and isoprenylation by geranylgeranyl pyrophosphate (GGpp). The latter post translational modification may be manipulated by agents such as3-hydroxy-3-methylglutaryl-CoA reductase inhibitors (HMGCRIs) that prevent de novo synthes is of isoprenoids such as GGpp. HMGCRI shave anti-inflammatory properties and substantially reduce infiltration of inflammatory immune cells into target tissues, including the central nervous system (CNS) during neuro inflammation. The depletion of the cellular is oprenoid pool is believed to result in the regulation of antigen specific T cells outside the target organand also to prevent migration of these cells in to target organs, such as the CNS. In vivo treatment with HMGCRI in the experimental autoimmune encephalitis (EAE) rodent model of multiple scleros is reduces the capacity of activated T cells to traffic to and with in the brain. This presentation shows that geranylgeranylation is fundamental for Rho Am ediated down stream events such as influencingcy to skeletal organization and the migration of T cells. Tethering of RhoA to them embrane by GGppis necessary for T cell migration and provides a mechanism by which HMGCRI may prevent T cell infiltration into inflamed compartments.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Radiology, Nuclear Medicine & Medical Imaging

B-1 inhomogeneity correction of RARE MRI at low SNR: Quantitative in vivo F-19 MRI of mouse neuroinflammation with a cryogenically-cooled transceive surface radiofrequency probe

Paula Ramos Delgado, Andre Kuehne, Mariya Aravina, Jason M. Millward, Alonso Vazquez, Ludger Starke, Helmar Waiczies, Andreas Pohlmann, Thoralf Niendorf, Sonia Waiczies

Summary: A model-based correction method was proposed and validated to quantify F-19 signals in inflamed mouse brains using F-19-CRP technology. The study showed significant improvements in signal quantification and concentration uncertainty maps, paving the way for future low-SNR F-19-MRI applications in vivo.

MAGNETIC RESONANCE IN MEDICINE (2022)

Article Clinical Neurology

Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis

Markus Bock, Falk Steffen, Frauke Zipp, Stefan Bittner

Summary: This study investigated the impact of adapted ketogenic diet (AKD) and caloric restriction (CR) on neuroaxonal damage in patients with multiple sclerosis (MS), and found that AKD significantly reduced serum neurofilament light chain (sNfL) levels.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)

Article Endocrinology & Metabolism

The Impact of Increased Maternal sFlt-1/PlGF Ratio on Motor Outcome of Preterm Infants

Lisa Middendorf, Alexandra Gellhaus, Antonella Iannaccone, Angela Koeninger, Anne-Kathrin Dathe, Ivo Bendix, Beatrix Reisch, Ursula Felderhoff-Mueser, Britta Huening

Summary: The sFlt-1/PlGF ratio does not predict the motor optimality score (MOS-R) in preterm infants, but low birth weight, which is correlated with an elevated ratio, has a negative effect on MOS-R outcome.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Physiology

Monitoring kidney size to interpret MRI-based assessment of renal oxygenation in acute pathophysiological scenarios

Kathleen Cantow, Thomas Gladytz, Jason M. Millward, Sonia Waiczies, Thoralf Niendorf, Erdmann Seeliger

Summary: This study used dynamic MRI to monitor kidney size and provided physiological interpretation of changes in renal oxygenation. The results showed correlations between changes in kidney size and T-2* and T-2. Monitoring kidney size allows for a better understanding of renal pathophysiology.

ACTA PHYSIOLOGICA (2023)

Article Immunology

Taste-immune associative learning amplifies immunopharmacological effects and attenuates disease progression in a rat glioblastoma model

Susann Hetze, Lennart Barthel, Laura Luckemann, Hauke S. Gunther, Clemens Wulfing, Yasmin Salem, Marie Jakobs, Tina Horbelt-Grunheidt, Jasmin Petschulat, Ivo Bendix, Ulrike Weber-Stadlbauer, Ulrich Sure, Manfred Schedlowski, Martin Hadamitzky

Summary: This study confirms the efficacy of using taste-immune associative learning with rapamycin in inhibiting GBM tumor growth while promoting the development of an anti-inflammatory anti-tumor microenvironment. These findings can serve as a reference for implementing learning protocols as alternative or supportive treatment strategies in clinical settings.

BRAIN BEHAVIOR AND IMMUNITY (2022)

Article Medicine, General & Internal

Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosis

Muriel Schraad, Timo Uphaus, Stefan Runkel, Walter Hitzler, Stefan Bittner, Frauke Zipp

Summary: This study aimed to investigate the response of multiple sclerosis (MS) patients to SARS-CoV-2 vaccination after disease-modifying therapy (DMT). The findings suggest that anti-CD20 treatment, decreased CD8 levels, and non-selective S1P treatment may lead to an insufficient response to SARS-CoV-2 vaccination. Close monitoring of anti-spike antibodies is recommended to customize vaccination regimens for these patients.

EBIOMEDICINE (2023)

Article Clinical Neurology

Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort

Falk Steffen, Timo Uphaus, Nina Ripfel, Vinzenz Fleischer, Muriel Schraad, Gabriel Gonzalez-Escamilla, Sinah Engel, Sergiu Groppa, Frauke Zipp, Stefan Bittner

Summary: Measuring serum neurofilament light chain (sNfL) levels can predict disease severity and future evidence of disease activity in patients with multiple sclerosis (MS). sNfL levels are also associated with the development of neurodegenerative damage.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2023)

Article Biochemistry & Molecular Biology

Growth-Restricted Fetuses and Offspring Reveal Adverse Sex-Specific Metabolic Responses in Preeclamptic Mice Expressing Human sFLT1

Rebekka Vogtmann, Mian Bao, Monia Vanessa Dewan, Alina Riedel, Rainer Kimmig, Ursula Felderhoff-Mueser, Ivo Bendix, Torsten Ploesch, Alexandra Gellhaus

Summary: Fetal adaptations to harmful intrauterine environments due to pregnancy disorders such as preeclampsia (PE) can negatively program the offspring's metabolism, resulting in long-term metabolic changes. In this study, researchers examined the consequences of sFLT1 overexpression in transgenic mice with PE/FGR on the offspring's metabolic phenotype. The results showed that sFLT1 overexpression led to growth-restricted fetuses with altered liver development and metabolic gene expression. The postnatal follow-up revealed increased weight gain and abnormal hormone levels in male PE offspring, suggesting adverse metabolic pre-programming specifically targeting males.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Oncology

Advanced Radio Frequency Applicators for Thermal Magnetic Resonance Theranostics of Brain Tumors

Nandita Saha, Andre Kuehne, Jason M. Millward, Thomas Wilhelm Eigentler, Ludger Starke, Sonia Waiczies, Thoralf Niendorf

Summary: This study designed circular and elliptical thermal magnetic resonance (ThermalMR) RF applicator arrays that combine loop antennas and self-grounded bow-tie (SGBT) dipole antennas for targeted radiofrequency (RF) induced heating and diagnostic magnetic resonance imaging (MRI) transmission. These hybrid designs showed superior MRI performance and targeted RF heating inside the tumor, while preserving healthy tissue. The results provide technical support for diagnostic and therapeutic interventions in brain tumors.

CANCERS (2023)

Article Immunology

Extracellular vesicles from immortalized mesenchymal stromal cells protect against neonatal hypoxic-ischemic brain injury

Nicole Labusek, Yanis Mouloud, Christian Koester, Eva Diesterbeck, Tobias Tertel, Constanze Wiek, Helmut Hanenberg, Peter A. Horn, Ursula Felderhoff-Mueser, Ivo Bendix, Bernd Giebel, Josephine Herz

Summary: By comparing the neuroprotective effects of EVs derived from primary MSCs and ciMSCs in a mouse model of brain injury, we found that ciMSC-EVs can effectively reduce neuroinflammation and promote neuroregeneration, showing similar neuroprotective effects as primary MSC-EVs. This suggests that ciMSCs are an ideal cell source for the scaled manufacturing of EV-based therapeutics to treat neonatal and possibly also adult brain injury, overcoming the heterogeneity issue of MSCs.

INFLAMMATION AND REGENERATION (2023)

Article Clinical Neurology

Prognostic value of single-subject grey matter networks in early multiple sclerosis

Vinzenz Fleischer, Gabriel Gonzalez-Escamilla, Deborah Pareto, Alex Rovira, Jaume Sastre-Garriga, Piotr Sowa, Einar A. Hogestol, Hanne F. Harbo, Barbara Bellenberg, Carsten Lukas, Serena Ruggieri, Claudio Gasperini, Tomas Uher, Manuela Vaneckova, Stefan Bittner, Ahmed E. Othman, Sara Collorone, Ahmed T. Toosy, Sven G. Meuth, Frauke Zipp, Frederik Barkhof, Olga Ciccarelli, Sergiu Groppa

Summary: This study investigated the prognostic value of longitudinal structural networks in predicting 5-year Expanded Disability Status Scale (EDSS) progression in relapsing-remitting multiple sclerosis (RRMS) patients. The study found that changes in network degree and global efficiency can predict disability accumulation independent of disease activity, and these network measures outperform conventional MRI predictors in predicting EDSS worsening.
Editorial Material Immunology

IL-17 receptor goes solo in autoimmune inflammation

Stefan Bittner, Frauke Zipp

Summary: IL-17-blocking antibodies have limited clinical effect in certain autoimmune diseases. This study demonstrates that SHP2-Act1 complexes can mediate IL-17R signaling autonomously, even in the absence of the IL-17 ligand itself.

IMMUNITY (2023)

Review Clinical Neurology

Implications of immunometabolism for smouldering MS pathology and therapy

Stefan Bittner, Katrin Pape, Luisa Klotz, Frauke Zipp

Summary: Worsening clinical symptoms in patients with multiple sclerosis (MS) are caused by inflammation specifically occurring within the CNS. This chronic and non-relapsing immune-mediated mechanism of disease progression, called "smouldering inflammation," is sustained by local factors in the CNS and explains why current MS treatments do not adequately target it. This review summarizes the current understanding of the local inflammatory microenvironment in smouldering inflammation, its interaction with immune cell metabolism, and potential treatments for preventing neurodegenerative damage.

NATURE REVIEWS NEUROLOGY (2023)

Article Medicine, Research & Experimental

First in vivo fluorine-19 magnetic resonance imaging of the multiple sclerosis drug siponimod

Ludger Starke, Jason M. Millward, Christian Prinz, Fatima Sherazi, Helmar Waiczies, Christoph Lippert, Marc Nazare, Friedemann Paul, Thoralf Niendorf, Sonia Waiczies

Summary: The study demonstrates that siponimod can be imaged non-invasively using 19F UTE MRI, laying the foundation for further preclinical and clinical investigations. This technique provides an accurate understanding of the distribution of CNS-acting drugs in individual patients, which can contribute to personalized therapy.

THERANOSTICS (2023)

Article Clinical Neurology

Improved prediction of early cognitive impairment in multiple sclerosis combining blood and imaging biomarkers

Tobias Brummer, Muthuraman Muthuraman, Falk Steffen, Timo Uphaus, Lena Minch, Maren Person, Frauke Zipp, Sergiu Groppa, Stefan Bittner, Vinzenz Fleischer

Summary: This study demonstrates that combining blood and imaging measures improves the accuracy of predicting cognitive impairment in early multiple sclerosis. The findings highlight the clinical utility of cross-modal biomarkers in multiple sclerosis patients who are likely to experience cognitive decline.

BRAIN COMMUNICATIONS (2022)

暂无数据